Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LGH447 |
| Trade Name | |
| Synonyms | LGB321|PIM447|LGH-447|PIM-447 |
| Drug Descriptions |
LGH447 is a pan-PIM protein kinase inhibitor, which leads to cell cycle arrest and growth inhibition in PIM-expressing tumor cells (PMID: 24474669, PMID: 30370255). |
| DrugClasses | PIM Inhibitor (Pan) 10 |
| CAS Registry Number | 1210608-43-7 |
| NCIT ID | C106259 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Alpelisib + LGH447 | Alpelisib LGH447 | 0 | 1 |
| Bortezomib + Dexamethasone + LGH447 | Bortezomib Dexamethasone LGH447 | 0 | 0 |
| Cytarabine + LGH447 | Cytarabine LGH447 | 0 | 0 |
| Dexamethasone + Lenalidomide + LGH447 | Dexamethasone LGH447 Lenalidomide | 0 | 0 |
| Dexamethasone + LGH447 | Dexamethasone LGH447 | 0 | 0 |
| Dexamethasone + LGH447 + Pomalidomide | Dexamethasone LGH447 Pomalidomide | 0 | 0 |
| LGH447 | LGH447 | 1 | 3 |
| LGH447 + Ribociclib + Ruxolitinib | LGH447 Ribociclib Ruxolitinib | 2 | 0 |